share_log

Atara Biotherapeutics | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

SEC ·  Feb 9, 2023 05:41
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more